Table 1.
Endothelin receptor antagonists used in experimental studies of Pulmonary Arterial Hypertension
| Drug | Selectivity | ETAKi | ETBKi | Orally active (yes/no) |
Models investigated | Effect (+) beneficial (o) no effect (−) harmful |
Investigator, Year |
|---|---|---|---|---|---|---|---|
| RO 47-0203 | ETA & ETB | 4.7 nM | 95 nM | Yes | Overcirculation | + | Rondelet, 2003 |
| (Bosentan) | Monocrotaline | + | Hill, 1997 | ||||
| Hypoxia | + | Holm, 1996 | |||||
| Hypoxia | + | Chen, 1995 | |||||
| Vascular Study | McCulloch, 1998 | ||||||
| SB217242 | ETA | 1.1 nM | 111 nM | Yes | Hypoxia | + | Underwood, 1998 |
| (Enrasentan) | Hypoxia | + | Underwood, 1997 | ||||
| Hypoxia | + | Underwood, 1999 | |||||
| Vascular Study | MacLean, 1998 | ||||||
| SB234551 | ETA | 0.1 nM | 500 nM | Yes | Vascular Study | MacLean, 1998 | |
| SB209670 | ETA & ETB | 0.2 nM | 12 nM | No | Vascular Study | McCulloch, 1998 | |
| Vascular Study | MacLean, 1998 | ||||||
| BSF420627 | ETA & ETB | 2.2 nM | 5.8 nM | Yes | Monocrotaline | + | Jasmin, 2001 |
| BQ123 | ETA | 22 nM | 18 µM | No | Overcirculation | + | Ivy, 1997 |
| Hypoxia | + | DiCarlo, 1995 | |||||
| Hypoxia | + | Oparil, 1995 | |||||
| Hypoxia | + | Bonvallet, 1994 | |||||
| Monocrotaline | + | Miyauchi, 1993 | |||||
| BQ-610 | ETA | 0.7 nM | 24 µM | No | Hypoxia | + | Ambalavanan, 2005 |
| Hypoxia | + | Ambalavanan, 2002 | |||||
| EMD122946 | ETA | 0.032 nM | 160 nM | No | Hypoxia | + | Ambalavanan, 2002 |
| TBC3711 | ETA | 0.08 nM | 26.3 µM | Yes | Hypoxia | + | Perreault, 2001 |
| TBC11251 | ETA | 1.4 nM | 9.8 µM | Yes | Monocrotaline | + | Tilton, 2000 |
| (Sitaxsentan) | |||||||
| TA-0201 | ETA | 0.015 nM | 41 nM | Yes | Monocrotaline | + | Ueno, 2000 |
| Monocrotaline | + | Ueno, 2002 | |||||
| BMS-193884 | ETA | 1.4 nM | 18.8 µM | Yes | Monocrotaline | + | Miyauchi, 2000 |
| ZD1611 | ETA | 8.6 nM | 5.6 µM | Yes | Hypoxia | + | Bialecki, 1999 |
| Hypoxia | + | Bialecki, 1998 | |||||
| FR 139317 | ETA | 1 nM | 7 µM | No | Vascular Study | McCulloch, 1998 | |
| ABT-627 | ETA | 0.034 nM | 63.3 nM | Yes | Monocrotaline | + | Nishida, 2004 |
| (Atrasentan) | Monocrotaline | + | Nishida, 2004 | ||||
| BMS 182874 | ETA | 55 nM | >200 µM | Yes | Vascular Study | McCulloch, 1998 | |
| YM598 | ETA | 0.697 nM | 569 nM | Yes | Hypoxia | + | Yuyama, 2005 |
| Monocrotaline | + | Yuyama, 2004 | |||||
| Monocrotaline | + | Fujimori, 2004 | |||||
| LU135252 | ETA | 1.4 nM | 140 nM | Yes | Monocrotaline | + | Jasmin, 2003 |
| (Darusentan) | Monocrotaline | + | Jasmin, 2001 | ||||
| Monocrotaline | + | Prie, 1998 | |||||
| Monocrotaline | + | Prie, 1997 | |||||
| Hypoxia | + | Blumberg, 2003 | |||||
| PD-155080 | ETA | 221.4 nM | 86.5 µM | Yes | Monocrotaline | + | Stessel, 2004 |
| PD-156707 | ETA | 0.17 nM | 133.8 nM | Yes | Overcirculation | + | Fratz, 2004 |
| Hypoxia | + | Sheedy, 1998 | |||||
| Hypoxia | + | Haleen, 1998 | |||||
| Vascular Study | Black, 2003 |